Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 222,879,429 papers from all fields of science
Search
Sign In
Create Free Account
tofenacin
Known as:
N-methyl-2-(o-methyl-alpha-phenylbenzyloxy)ethyl amine
, demethylorphenadrine
, tofenacine
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
6 relations
Broader (3)
Cholinergic Antagonists
Disipal
Orphenadrine
Narrower (2)
Elamol
tofenacin hydrochloride
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1989
1989
Residual Neuroleptic-Induced Parkinsonian Symptoms in Schizophrenia
A. Altamura
,
M. Mauri
,
F. D. Novellis
,
M. Percudani
,
V. Vampini
Pharmacopsychiatry
1989
Corpus ID: 39693625
A naturalistic study was performed on 44 schizophrenic outpatients diagnosed according to DSM III-R and presenting neuroleptic…
Expand
1988
1988
Identification of structural characteristics of some potential H2-receptor antagonists that determine the interaction with rat hepatic P-450.
E. Rekka
,
G. Sterk
,
H. Timmerman
,
A. Bast
Chemico-Biological Interactions
1988
Corpus ID: 39289539
1987
1987
Cytochrome P450 metabolic intermediate complex of nefopam
R. Leurs
,
D. Donnell
,
H. Timmerman
,
A. Bast
The Journal of pharmacy and pharmacology
1987
Corpus ID: 12419584
NADPH‐catalysed biotransformation of nefopam in liver microsomes obtained from phenobarbitone‐pretreated rats leads to the…
Expand
1984
1984
Inhibition of mono-oxygenase and oxidase activity of rat-hepatic cytochrome P-450 by H2-receptor blockers.
A. Bast
,
E. Savenije-Chapel
,
B. Kroes
Xenobiotica; the fate of foreign compounds in…
1984
Corpus ID: 23601420
Of four H2 blockers, cimetidine, tiotidine, oxmetidine and ranitidine, all except ranitidine showed ligand (type II) interactions…
Expand
1983
1983
Product inhibition in orphenadrine metabolism as a result of a stable cytochrome P-450-metabolic intermediate complex formed during the disposition of mono-N-desmethylorphenadrine (tofenacine) in the…
A. Bast
,
F. A. van Kemenade
,
E. Savenije-Chapel
,
J. Noordhoek
Research communications in chemical pathology and…
1983
Corpus ID: 24751133
Product inhibition is thought to be involved in unexpected accumulation of orphenadrine, which occurs during chronic medication…
Expand
1982
1982
Spectral interaction of orphenadrine and its metabolites with oxidized and reduced hepatic microsomal cytochrome P-450 in the rat.
A. Bast
,
J. Noordhoek
Biochemical Pharmacology
1982
Corpus ID: 35917218
1978
1978
A Comparison of the inhibitory effects of aromatic substituted benzhydryl ethers on the uptake of catecholamines and serotonin into synaptosomal preparations of the rat brain
P. Zee
,
W. Hespe
Neuropharmacology
1978
Corpus ID: 30625979
1971
1971
An evaluation of tofenacine (elamol), a new drug for the treatment of depression.
G. Bram
,
N. Shanmuganathan
Current Therapeutic Research
1971
Corpus ID: 33080836
1968
1968
The concentrations of orphenadrine and its N-demethylated derivatives in rat brain, after intraperitoneal administration of orphenadrine and tofenacine.
R. C. Roozemond
,
W. Hespe
,
W. Nauta
International Journal of Neuropharmacology
1968
Corpus ID: 39760294
1966
1966
The effect of orphenadrine and its N-demethyl derivative on the level of 5-hydroxytryptamine in rat brain.
R. C. Roozemond
,
W. Nauta
International Journal of Neuropharmacology
1966
Corpus ID: 20663131
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE